Navigation Links
Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
Date:11/5/2010

Important safety informationRisk of Serious Infections and MalignancyPatients treated with certolizumab pegol are at an increased risk for developing serious infections that may lead to hospitalization or death.  Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.  Certolizumab Pegol should be discontinued if a patient develops a serious infection or sepsis.  Reported infections include:

  • Active tuberculosis, including reactivation of latent tuberculosis.  Patients with tuberculosis have frequently presented with disseminated or extrapulmonary disease.  Patients should be tested for latent tuberculosis before certolizumab pegol use and during therapy.  Treatment for latent infection should be initiated prior to certolizumab pegol use.
  • Invasive fungal infections, including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis.  Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather than localized disease.  Antigen and antibody testing for histoplasmosis may be negative in some patients with active infection.  Empiric anti-fungal therapy should be considered in patients at risk for invasive fungal infections who develop severe systemic illness.
  • Bacterial, viral and other infections due to opportunistic pathogens.

  • The risks and benefits of treatment with certolizumab pegol should be carefully considered prior to initiating therapy in patients with chronic or recurrent infection.  Patients should be closely monitored for the development of signs and symptoms of infection during and after treatment with certolizumab pegol, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy.Lymphoma and other mal
    '/>"/>

    SOURCE UCB
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
    2. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
    3. Installation of Next Generation Proton Therapy System Progressing Rapidly
    4. endpoint Launches PULSE 2.0 Allowing Clinical Research Teams to Save Additional Time and Money By Rapidly Deploying Studies With Custom Reporting
    5. Radiation Oncology Expert From Stanford University Highlights How Image Guidance and RapidArc® Technology are Improving the Treatment of Lung Cancer
    6. Sagent Pharmaceuticals Announces Launch of ANEclear Device for Rapid Clearance of Inhaled Anesthetics Following Surgery
    7. New Institute Paves Way for Rapid Cancer Drug Development
    8. Chongqing Cancer Hospital Becomes First Hospital in Southwest China to Offer Cancer Patients Fast, Precise Treatment Using RapidArc® Radiotherapy from Varian Medical Systems
    9. Medco Completes Acquisition of United BioSource Corporation, Creating Powerful Engine for Rapidly Advancing Clinical Insight and Innovation
    10. Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems
    11. Cancer Patients in Scotland Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health care ... new IT value-added reseller (VAR) national contracts that expand ... and services at lower costs. These include manufacturer product ... as initiative assistance and ongoing IT consulting support. ...
    (Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
    (Date:1/15/2014)... 15, 2014  Manufacturers, suppliers and distributors of innovative ... protect their most important business assets, intellectual property ... Because of the highly-competitive nature of ... of the most litigious industry sectors of cases ...
    Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
    ... , LAKE FOREST, Ill., Dec. 16 Hospira, ... pharmaceutical and medication delivery company, today announced that it will ... 2009 results and projections for 2010 on Thursday, Feb. 4, ... release its fourth-quarter and full-year 2009 results earlier that morning, ...
    ... , GREEN BAY, Wis., Dec. ... with DolCas Biotech for the use of super ... multiple EuroPharma formulations. The exclusive distribution territory ... food store channel and professional channel, which includes ...
    Cached Medicine Technology:EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3
    (Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
    (Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
    (Date:4/17/2014)... (April 16, 2014) The cause of neuronal death ... study proposes that neurons may be mistaken for foreign ... similar to the way autoimmune diseases like type I ... cells. The study was published April 16, 2014, in ... and likely controversial, idea in Parkinson,s disease; but if ...
    (Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
    (Date:4/17/2014)... Population Council scientists and their partners have found that ... prevent the transmission of multiple sexually transmitted infections (STIs) ... herpes simplex virus 2 (HSV-2), and human papillomavirus (HPV). ... the gel is effective against multiple strains of HIV, ... against all three viruses of at least eight hours ...
    Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
    ... ... MomAtLast.com , ... March 31, 2010 -- Phenomenal moms-helping-moms-to-be website MomAtLast.com announces a “ share your journey ... great resource for women of all ages who are trying to become parents – ...
    ... , ... to Increase Local Enrollment of Medical Clinical Trials , ... (PRWEB) March 29, 2010 -- In a move ... patient care site Accumed Research Associates of Garden City, NY on long Island has ...
    ... To ... offering a free virtual conference with 17 different presenters over two days on Saturday April ... free. , ... March 31, 2010 -- In honor of Autism Awareness month, momsfightingautism.com is offering a free ...
    ... ... with an exciting multi-media event at the Hilton Americas in Houston, Texas on March ... ... of CieAura Transparent Holographic Chips™, successfully launched its direct sales company with an exciting ...
    ... ... an internationally recognized leader in literacy research, remediation, and professional development, will help ... beginning April 1st, 2010. , ... San Luis Obispo, CA (Vocus) -- Lindamood-Bell Learning ...
    ... patients walking back to health with shelter dogs , TUESDAY, ... getting a new "leash" on life as they gain strength ... innovative program, called Cardiac Friends, is a partnership between ProHealth ... County, in Wisconsin. , "It,s a great way to help ...
    Cached Medicine News:Health News:Share the Story Of How You Became a 'Mom At Last' And Win $100 2Health News:Accumed Research Associates Launches Official Website 2Health News:Accumed Research Associates Launches Official Website 3Health News:First Ever Virtual Autism Conference Featuring Temple Grandin and 16 speakers to discuss: “Things To Know About Autism” April 10th-11th. 2Health News:First Ever Virtual Autism Conference Featuring Temple Grandin and 16 speakers to discuss: “Things To Know About Autism” April 10th-11th. 3Health News:CieAura Launches Successfully with Over 3000 Attendees 2Health News:CieAura Launches Successfully with Over 3000 Attendees 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 2Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 3Health News:Lindamood-Bell to Help Commemorate Autism Awareness Day 4Health News:Man's Best Friend Helps Mend Broken Hearts 2Health News:Man's Best Friend Helps Mend Broken Hearts 3
    ... in gloves, Polymed has become even better. Polymed® ... of regular Polymed with the exciting addition of ... of antioxidants, which are vital to healthy skin. ... powder-free to reduce the potential for latex sensitization. ...
    ... DRAPE. Soft translucent material ... Latex finger cot with ... base. Full-width 50mm adhesive ... with finger lift for ...
    CYSTOSCOPY "T". DRAPE...
    Urological Drape Aggressive adhesive with no residue Latex-free finger cot Strong, low-glare matte finish film Non-linting, tear resistant poly release liner...
    Medicine Products: